To equip cardiologists and other cardiovascular care providers with the knowledge and clinical insights necessary to evaluate and integrate emerging Factor XI inhibitors into practice, optimizing anticoagulation strategies for patients with atrial fibrillation (AF), non-cardioembolic stroke, comorbid conditions such as end-stage renal disease (ESRD) and cancer.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
All courses included · $299 – $699/yr
Courses are included in the subscription; some are also sold individually.
| Reduced Member (FIT, Emeritus, CVT) | $299/yr |
| Physician Member | $599/yr |
| Nonmember | $699/yr |
Collected from the provider’s public pages · source
Top 6 courses
-
-
iMAGINE 2026 Do it, But Do it Well
10.75 Credits
-
-
-
-
Specialties served/covered
- Advanced Heart Failure & Transplant Cardiology
- Cardiovascular Disease
- Clinical Cardiac Electrophysiology
- Comprehensive & Board Review
- Critical Care Medicine
- Diagnostic Radiology
- Endocrinology, Diabetes & Metabolism
- General Internal Medicine
- Hospice & Palliative Medicine
- Interventional Cardiology
- Interventional Radiology
- Medical Oncology
- Nuclear Medicine
- Patient Safety & Quality Improvement
- Pediatric Cardiology
- Pediatric Hematology-Oncology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- Internal Medicine
- Medical Subspecialties
- Oncology & Hematology
- Pain & Palliative
- Radiology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 0.5 credits
- MOC · Up to 0.5 points
- Commercial Support
-
ReleasedMay 1, 2026
-
Last day to claim creditMay 2, 2027 7 months left
-
Answers in CME Inc. (AiCME) What s Next in Anticoagulation? An Evolving Primary Care Playbook for Stroke Prevention in Atrial Fibrillation
-
International Society on Thrombosis and Haemostasis +1 Evaluating the potential of factor XI/factor XIa inhibitors to address unmet anticoagulation needs in critical patient populations
-
Medscape, LLC Personalizing Antithrombotic Care: A Case-Based Look at Factor XIa Inhibition After Stroke
-
American College of Cardiology Foundation Putting the Guidelines Into Practice: Building a State-of-the-Art Lipid and Cardiometabolic Clinic (ACC.26 CSS)
-
American College of Cardiology Foundation Hypertriglyceridemia and Cardiovascular Health: Recognizing Risks and Tackling Management (ACC.26 CSS)
-
American College of Cardiology Foundation 2023 Atrial Fibrillation Guidelines: An Overview
